The medication is typically started at a low dose (0.25 mg weekly) and gradually increased to therapeutic doses of 0.5 mg, 1 mg, or 2 mg weekly, depending on individual response and tolerability
It can also be used in the management of PCOS, and has been shown to restore ovulation, reduce weight, reduce circulating androgen levels, reduce the risk of miscarriage, and reduce the risk of gestational diabetes
However, studies from 1997 to 2012 suggested that obesity rates began rising after we lowered red meat and whole-fat dairy consumption and substituted butter with margarine
For most patients, it resolves substantially after the first few weeks of a given dose
Pediatrics 109(1):150152
Science 215:11151116 Petersen KF, Sullivan JT (2001) Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans